Skip to main content
Clinical Trials/NCT03509324
NCT03509324
Completed
Phase 4

Effectiveness and Determinants of Glucose Control, β-cell Function in Response to Short-term Intensive Insulin Pump Therapy in Different Duration of Type 2 Diabetes Mellitus.

Sun Yat-sen University1 site in 1 country67 target enrollmentMarch 1, 2015

Overview

Phase
Phase 4
Intervention
Insulin LISPRO
Conditions
Diabetes Mellitus, Type 2
Sponsor
Sun Yat-sen University
Enrollment
67
Locations
1
Primary Endpoint
fasting plasma glucose after insulin therapy
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to investigate and evaluate the significance of intravenous glucose tolerance test in assessment of β-cell function improvement after short course of intensive insulin therapy, trying to illustrate the relationship between fasting plasma glucose and acute insulin release under different stage of type 2 diabetes with poor glycemic control.

Registry
clinicaltrials.gov
Start Date
March 1, 2015
End Date
June 30, 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Sun Yat-sen University
Responsible Party
Principal Investigator
Principal Investigator

Yanbing Li

Director of Endocrinology Department

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • different course of type 2 diabetes with poor glycemic control

Exclusion Criteria

  • acute complication or severe comorbidities

Arms & Interventions

duration of disease

different duration of disease receive insulin LISPRO

Intervention: Insulin LISPRO

Outcomes

Primary Outcomes

fasting plasma glucose after insulin therapy

Time Frame: 10 hour

Study Sites (1)

Loading locations...

Similar Trials